Kathleen Seyb

956 citations

19 papers · 546 indexed · h-index 14

Co-authors: Marcie A. Glicksman Mary L. Michaelis Sabah Ansar Gregory D. Cuny Li‐Ching Lai Qiongman Kong Kenneth L. Audus Richard H. Himes
Topics: Alzheimer's disease research and treatments (5 papers)Complement system in diseases (4 papers)Cholinesterase and Neurodegenerative Diseases (3 papers)
Cited by: Cellular and Molecular Neuroscience Neurology Biological Psychiatry
Journals: Journal of Clinical Investigation Blood PLoS ONE
Partner nations: United States Sweden India

In The Last Decade

Kathleen Seyb

19 papers receiving 541 citations

Peers

Countries citing papers authored by Kathleen Seyb

Since Specialization

Citations

This map shows the geographic impact of Kathleen Seyb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Seyb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Seyb more than expected).

Fields of papers citing papers by Kathleen Seyb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Seyb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Seyb. The network helps show where Kathleen Seyb may publish in the future.

Co-authorship network of co-authors of Kathleen Seyb

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Seyb. A scholar is included among the top collaborators of Kathleen Seyb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Seyb. Kathleen Seyb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis 2019 ·Kidney International ·(unknown),Nicholas Medjeral‐Thomas,(unknown),Pritesh Trivedi,Kathleen Seyb,Ramin Farzaneh‐Far,Iva Gunnarsson,Agneta Zickert,Thomas Cairns,Liz Lightstone,H. Terence Cook,Matthew C. Pickering	34
2	RA101495 abolishes residual complement activity observed in the presence of eculizumab 2017 ·Molecular Immunology ·Alonso Ricardo,(unknown),Zhong Ma,(unknown),Kathleen Seyb,Guoqing Tang,Douangsone D. Vadysirisack	1
3	Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation 2016 ·Scientific Reports ·Zijiang Yang,John Concannon,Kelvin S. Ng,Kathleen Seyb,Luke J. Mortensen,Sudhir H. Ranganath,(unknown),Oren Levy,Zhixiang Tong,(unknown),Weian Zhao,Charles P. Lin,Marcie A. Glicksman,Jeffrey M. Karp	25
4	Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis 2015 ·PLoS ONE ·Gunjan D. Manocha,Kendra L. Puig,Susan A. Austin,Kathleen Seyb,Marcie A. Glicksman,Colin K. Combs	14
5	Preclinical Evaluation of RA101495, a Potent Cyclic Peptide Inhibitor of C5 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria 2015 ·Blood ·Alonso Ricardo,(unknown),Steven J. DeMarco,(unknown),Robert E. Hammer,Masha Fridkis‐Hareli,(unknown),Kathleen Seyb,Guoqing Tang,Sylvia Tobé,Douglas A. Treco	27
6	Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors 2014 ·SLAS DISCOVERY ·Dariusz Pytel,Kathleen Seyb,Min Liu,Soumya S. Ray,John Concannon,Mickey Huang,Gregory D. Cuny,J. Alan Diehl,Marcie A. Glicksman	22
7	Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs 2014 ·Antiviral Research ·Parmjeet Randhawa,Gang Zeng,Marta Bueno,(unknown),Andrew Lesniak,Kumiko Isse,Kathleen Seyb,A. Perry,Ian G. Charles,(unknown),Mingqian Huang,Megan L. Smith,Marcie A. Glicksman	10
8	Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases 2014 ·Blood ·Alonso Ricardo,(unknown),Steven J. DeMarco,(unknown),Robert E. Hammer,Kristopher Josephson,Kathleen Seyb,Sylvia Tobé,Zhaolin Wang,Hong Zheng,Douglas A. Treco	7
9	Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection 2014 ·Journal of Clinical Investigation ·Qiongman Kong,Ling‐Chu Chang,Kou Takahashi,Qibing Liu,(unknown),Li‐Ching Lai,(unknown),Yu–Chen Lin,(unknown),(unknown),Xuechao Xing,Kathleen Seyb,Gregory D. Cuny,Marcie A. Glicksman,Chien‐liang Glenn Lin	116
10	Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization. 2012 ·PubMed ·(unknown),Ella Zeldich,Kathleen Seyb,Mickey Huang,John Concannon,Gwendalyn D. King,Ci-Di Chen,Gregory D. Cuny,Marcie A. Glicksman,Carmela R. Abraham	17
11	A High-Throughput Screening Method for Small-Molecule Inhibitors of the Aberrant Mutant SOD1 and Dynein Complex Interaction 2011 ·SLAS DISCOVERY ·Xiaohu Tang,Kathleen Seyb,Mickey Huang,Eli Schuman,Ping Shi,Haining Zhu,Marcie A. Glicksman	8
12	Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2—Discovery of LRRK2 inhibitors 2010 ·Analytical Biochemistry ·Min Liu,Shibu M. Poulose,Eli Schuman,(unknown),(unknown),(unknown),Kathleen Seyb,Gregory D. Cuny,Marcie A. Glicksman,Ross L. Stein,Zhenyu Yue	24
13	Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity 2010 ·SLAS DISCOVERY ·Craig K. Colton,Qiongman Kong,Li‐Ching Lai,Michael X. Zhu,Kathleen Seyb,Gregory D. Cuny,Jun Xian,Marcie A. Glicksman,Chien-Liang Lin	65
14	Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Lixin Qiao,Sung‐Woon Choi,April Case,(unknown),Kathleen Seyb,Marcie A. Glicksman,Donald C. Lo,Ross L. Stein,Gregory D. Cuny	22
15	Identification of Small Molecule Inhibitors of β-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform 2008 ·SLAS DISCOVERY ·Kathleen Seyb,Eli Schuman,Jake Ni,(unknown),Mary L. Michaelis,Marcie A. Glicksman	14
16	p35/Cyclin-dependent kinase 5 is required for protection against β-amyloid-induced cell death but not tau phosphorylation by ceramide 2007 ·Journal of Molecular Neuroscience ·Kathleen Seyb,Sabah Ansar,(unknown),(unknown),Mary L. Michaelis,Rick T. Dobrowsky	6
17	β-Amyloid and Endoplasmic Reticulum Stress Reponses in Primary Neurons: Effects of Drugs That Interact With the Cytoskeleton 2006 ·Journal of Molecular Neuroscience ·Kathleen Seyb,Sabah Ansar,(unknown),Mary L. Michaelis	40
18	β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Mary L. Michaelis,Sabah Ansar,(unknown),(unknown),Kathleen Seyb,Richard H. Himes,Kenneth L. Audus,Gunda I. Georg	78
19	Cytoskeletal Integrity as a Drug Target 2005 ·Current Alzheimer Research ·Mary L. Michaelis,Kathleen Seyb,Sabah Ansar	16

About Kathleen Seyb

Kathleen Seyb is a scholar working on Genetics, Developmental Neuroscience and Pharmacology, having authored 19 papers that have together received 546 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Complement system in diseases (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (183 citations), Neurology (53 citations) and Biological Psychiatry (16 citations). Kathleen Seyb has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Marcie A. Glicksman, Mary L. Michaelis, Sabah Ansar, Gregory D. Cuny, Li‐Ching Lai, Qiongman Kong, Kenneth L. Audus, Richard H. Himes, Gunda I. Georg and Xuechao Xing. Their work appears in journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact